Addendum: B-cell lymphoblastic lymphoma following intravenous BNT162b2 mRNA booster in a BALB/c mouse: a case report

Frontiers in Oncology

Oncology

Pieter-Jan Guns¹  Sander Eens²  Kasper Favere³  Thomas Tousseyn⁴  Manon Van Hecke⁴  Tania Roskams⁴  Hein Heidbuchel⁵ 

[1] Laboratory of Physiopharmacology, Genetics, Pharmacology and Physiopathology of Heart, Blood Vessels and Skeleton (GENCOR), University of Antwerp, Antwerp, Belgium;Laboratory of Physiopharmacology, Genetics, Pharmacology and Physiopathology of Heart, Blood Vessels and Skeleton (GENCOR), University of Antwerp, Antwerp, Belgium;Research Group Cardiovascular Diseases, Genetics, Pharmacology and Physiopathology of Heart, Blood Vessels and Skeleton (GENCOR), University of Antwerp, Antwerp, Belgium;Laboratory of Physiopharmacology, Genetics, Pharmacology and Physiopathology of Heart, Blood Vessels and Skeleton (GENCOR), University of Antwerp, Antwerp, Belgium;Research Group Cardiovascular Diseases, Genetics, Pharmacology and Physiopathology of Heart, Blood Vessels and Skeleton (GENCOR), University of Antwerp, Antwerp, Belgium;Department of Cardiology, Antwerp University Hospital, Antwerp, Belgium;Department of Internal Medicine, Ghent University, Ghent, Belgium;Laboratory of Translational Cell and Tissue Research, Department of Imaging and Pathology, University of Leuven, Leuven, Belgium;Research Group Cardiovascular Diseases, Genetics, Pharmacology and Physiopathology of Heart, Blood Vessels and Skeleton (GENCOR), University of Antwerp, Antwerp, Belgium;Department of Cardiology, Antwerp University Hospital, Antwerp, Belgium;

关键词: lymphoma;    B-cell;    lymphoblastic;    COVID-19;    mRNA vaccine;    BNT162b2;    mouse;    BALB/c;   

DOI  :  10.3389/fonc.2023.1267904

 received in 2023-10-01, accepted in 2023-10-06,  发布年份 2023

来源: Frontiers

【 授权许可】

Unknown   
Copyright © 2023 Eens, Van Hecke, Favere, Tousseyn, Guns, Roskams and Heidbuchel